Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/1995
09/14/1995CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995CA2184583A1 Transforming growth factor alpha h1
09/14/1995CA2184358A1 Glioblastoma-derived angiogenesis inhibiting factor
09/14/1995CA2183961A1 Fibroblast growth factor-10
09/14/1995CA2182800A1 Method of stimulating hematopoiesis with hemoglobin
09/14/1995CA2182103A1 9-deoxotaxane compounds
09/13/1995EP0671410A1 Antiviral compounds
09/13/1995EP0671409A2 Malonic acid derivatives having anti-adhesive properties
09/13/1995EP0671408A2 Carbohydrate mimetics having anti-adhesive properties
09/13/1995EP0671407A2 Sulfated alpha-glycolipid derivatives as cell adhesion inhibitors
09/13/1995EP0671399A1 6,7-Epoxy paclitaxels
09/13/1995EP0671156A1 Cosmetic or pharmaceutical compositions containing liposomes
09/13/1995EP0671005A1 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression
09/13/1995EP0670904A1 Vector for the expression of therapy-relevant genes
09/13/1995EP0670899A1 Heat shock proteins and the treatment of tumours
09/13/1995EP0670897A1 ANTISENSE OLIGONUCLEOTIDE INHIBITION OF THE ras GENE
09/13/1995EP0670839A1 Process for the preparation of 9-amino camptothecin
09/13/1995EP0529002A4 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes
09/13/1995EP0513068B1 Three new non-polyglutamatable deazaaminopterins and process for preparing the same
09/13/1995EP0383770B1 Inhibition of eucaryotic pathogens and neoplasms with lytic peptides
09/13/1995CN1108454A Anthracycline conjugates, their preparation and their use as antitumor agents
09/13/1995CN1108245A Vitamin D3 analogs
09/13/1995CN1108100A Methods of inhibiting breast disorders
09/13/1995CN1108094A Methods for treating resistant neoplasms
09/12/1995US5449798 Phospholipid derivatives containing higher elements of the fifth group
09/12/1995US5449773 Antitumor agents
09/12/1995US5449766 DNA encoding NEI and NGE peptides
09/12/1995US5449753 Autotaxin: motility stimulating protein useful in cancer diagnosis
09/12/1995US5449690 Naphthylethylureas and naphthylethylthioureas
09/12/1995US5449689 Naphthylethylureas and naphthylethylthioureas
09/12/1995US5449684 Antitumor agents and viricides
09/12/1995US5449663 L-Glucose
09/12/1995CA2144390A1 Malonic acid derivatives having antiadhesive properties
09/12/1995CA2144388A1 Carbohydrate mimetics having antiadhesive properties
09/11/1995CA2143013A1 6,7-epoxy paclitaxels
09/08/1995WO1995023867A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
09/08/1995WO1995023855A2 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995WO1995023790A1 Cytokine inhibiting imidazole substituted hydroxamic acid derivatives
09/08/1995WO1995021927A3 Targeting gene therapy
09/08/1995CA2184580A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/08/1995CA2184113A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
09/06/1995EP0670369A2 A novel peptide related to human programmed cell death and DNA encoding it
09/06/1995EP0670366A1 Proteic extract from Cucumis melo with antioxidant activity and process of preparation, cosmetic or pharmaceutic composition or food composition containing such extract
09/06/1995EP0670162A1 Pharmaceutical formulations containing raloxifere, a surfactant and a watersoluble diluent
09/06/1995EP0669988A1 Angiogenesis inhibitory antibodies
09/06/1995EP0669982A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
09/06/1995EP0669978A1 Flk-1 is a receptor for vascular endothelial growth factor
09/06/1995EP0669976A1 Transcription factor dp-1
09/06/1995EP0669931A1 17-alpha-acyl steroids which inhibit 5-alpha-reductase
09/06/1995EP0669930A1 Cellular genes encoding retinoblastoma-associated proteins
09/06/1995EP0669927A1 Sequence-specific binding polymers for duplex nucleic acids
09/06/1995EP0669918A1 Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
09/06/1995EP0669916A1 Novel method for preparing taxane derivatives, novel derivatives thus obtained and compositions containing them.
09/06/1995EP0669833A1 USES OF TGF-$g(b) RECEPTOR FRAGMENT AS A THERAPEUTIC AGENT
09/06/1995EP0669827A1 Compositions for the regulation of cytokine activity
09/06/1995EP0574416B1 Poly-4-aminopyrrole-2-carboxyamide derivatives, processes for their preparation and pharmaceutical compositions which contain them
09/06/1995CN1107839A Carbox amide
09/05/1995USH1487 Antitumor agents; treatment of ovarian, breast and other cancers
09/05/1995US5447959 Vitamin A derivatives
09/05/1995US5447956 Treatment of leukemia with a imidazo carbamate
09/05/1995US5447950 Anthra[1,9-c,d]pyrazol-6-(2H)-ones useful for treating anaerobic bacterial infections
09/05/1995US5447936 Anticarcinogenic agents in dimethylacetamide solutions and carboxylic acids
09/05/1995US5447929 Collagenase inhibitors for degenerative joint disease, antitumor agents or atherosclerosis
09/05/1995US5447928 Antiischemic agents and nervous system disorders
09/05/1995US5447924 Vitamin D analogues
09/05/1995US5447913 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
09/05/1995US5447911 Antitumor agents
09/05/1995US5447719 β-glucuronidase inhibitor
09/05/1995CA2143514A1 Antitumor compositions and methods of treatment
09/05/1995CA2142154A1 Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors
09/05/1995CA2039874C 4'-demethylepipodophyllotoxin glycosides
09/05/1995CA1336889C Treatment of iodine deficiency diseases
09/05/1995CA1336887C Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
09/02/1995CA2143603A1 Fatty acid derivatives
08/1995
08/31/1995WO1995023234A1 Isolated, tyrosinase derived peptides and uses thereof
08/31/1995WO1995023145A1 New anthraquinonic derivatives having an antitumor activity, and applications thereof
08/31/1995WO1995023141A1 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents
08/31/1995WO1995022966A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
08/31/1995CA2184093A1 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
08/31/1995CA2161318A1 New anthraquinonic derivatives having an antitumor activity, and applications thereof
08/30/1995EP0669001A1 Determination of peptide motifs on mhc molecules.
08/30/1995EP0668933A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy
08/30/1995EP0668923A1 Monoclonal antibody
08/30/1995EP0668856A1 Inhibitors of farnesyl-protein transferase
08/30/1995EP0668854A1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacentates or n, n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress
08/30/1995EP0668782A1 Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer
08/30/1995EP0668781A1 Lymphokine gene therapy of cancer
08/30/1995EP0668777A1 Prostate-specific membrane antigen
08/30/1995EP0668770A1 $g(a)-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
08/30/1995EP0668769A1 Synthetic compositions related to oak bark extrakt, and method of using same
08/30/1995EP0668762A1 Butenyl-substituted taxanes and composition
08/30/1995EP0485577B1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
08/30/1995EP0428541B1 Collagen wound healing matrices and process for their production
08/30/1995CN1107367A Stabilized pharmaceutical compositions and stabilizing solvent
08/30/1995CN1107354A Cancer treating pill and its preparing process
08/30/1995CN1107353A Pill for treatment of cancer and its preparing process
08/30/1995CN1107352A Oral liquid for treatment of cancer and its preparing process
08/30/1995CN1107351A Powder for treatment of cancer and its preparing process
08/30/1995CN1107331A Sustained release pharmaceutical composition
08/29/1995US5446187 Antitumor agent
1 ... 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 ... 2211